tirzepatide replacement Specialist Near Me in San Antonio, TX Hormone therapy supercharges weight loss

At least 12 large players will soon launch their injections, Satviki Sanjay reports: P.S

Oral semaglutide (Rybelsus) is the only tablet form currently available

Hanmi Pharmaceutical leads the pack Having completed Phase 3 clinical trials in Korea for Efpeglenatide, a weekly injectable GLP-1 drug, aiming for launch in the second half of 2026 Promises fewer side effects and added benefits like reduced cardiovascular and kidney risks Expected to be priced lower than imports like Wegovy, thanks to local production Also working on next-gen drugs: HM15275 shows faster, more effective weight loss than current drugs

Work with a registered dietitian if you need help with meal planning

Are GLP-1 medications approved for type 1 diabetes